Khaitan & Co. advised Pathkind Diagnostics Private Limited on the deal.Motilal Oswal Private Equity (MOPE) executed an investment of approx. ?194.4 crore ($25 million) in Mankind Pharma’s…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
